Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.04 -0.02 (-33.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Nymox Pharmaceutical (NYMXF) Short term Debt (2015 - 2021)

Updated

Nymox Pharmaceutical's Short term Debt was $445,000 in Q3 2021, up 45.0% from the prior quarter.

Analysis

Nymox Pharmaceutical (NYMXF) Short term Debt (2015 - 2021) Analysis & Trends

At the end of FY2020, Short term Debt at Nymox Pharmaceutical came in at $368,000.

  • Short term Debt shows a five-year compound annual growth rate of -14.7% (FY2015 to FY2020).
  • In earlier years, Short term Debt was $3,000 in FY2019 and $931,000 in FY2016 (+14.4%).
  • The Q3 2021 figure marks the highest quarterly Short term Debt since Q4 2016.
  • Per Business Quant data, NYMXF's Short term Debt in the three quarters before Q3 2021 was $307,000 (Q2 2021), $338,000 (Q1 2021) and $368,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Nymox Pharmaceutical 6.12 Mn 5.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 445,000.00
Jun 30, 2021 307,000.00
Mar 31, 2021 338,000.00
Dec 31, 2020 368,000.00
Dec 31, 2019 3,000.00
Dec 31, 2016 931,000.00
Dec 31, 2015 814,000.00
API Access

Nymox Pharmaceutical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NYMXF&period=max&api_key=YOUR_API_KEY